Atrial fibrillation: Prevalence, risk factors and mortality in a large French population with 15 years of follow-up;Fibrillation atriale: Prévalence, facteurs de risque et mortalité dans une vaste population française suivie 15 ans

Bulletin de l'Academie Nationale de Medecine

Volumn 191, Issue 4-5, 2007, Pages 791-805

  Guize, Louis ^a,b   Thomas, Frédérique ^a,b   Bean, Kathy ^a,b   Benetos, Athanase ^a,b   Pannier, Bruno ^a,b  

^a Preventive and Clinical Investigation Center IPC   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Atrial fibrillation; Cardiovascular diseases mortality; Cerebovascular accident mortality; Epidemiology; Mortality; Risk factors

Indexed keywords

AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; FEMALE; FOLLOW UP; FRANCE; HEART ATRIUM FIBRILLATION; HUMAN; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; RISK; RISK FACTOR; SEX DIFFERENCE; STATISTICAL ANALYSIS; STROKE; TIME;

AGE FACTORS; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CARDIOVASCULAR DISEASES; DATA INTERPRETATION, STATISTICAL; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; RISK; RISK FACTORS; SEX FACTORS; STROKE; TIME FACTORS;

EID: 39549084086     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)33017-1     Document Type: Article

References (35)

1. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillationexecutive summary. Eur. Heart J., 2006, 27, 1979-2030.
2. RYDER K.M., BENJAMIN E.J. - Epidemiology and significance of atrial fibrillation. Am. J. Cardiol., 1999, 84, 131R-138R.
3. KRAHN A.D., MANFREDA J., TATE R.B., MATHEWSON F.A.L., CUDDY T.E. - The Natural History of Atrial Fibrillation : Incidence, Risk Factors, and Prognosis in the Manitoba Follow-up Study. Am. J. Med, 1995, 98, 476-484.
4. GoA.S.,HYLEKE.M.,MANOLIOT.A.- Prevalenceofdiagnosedatrialfibrillationinadults: nationalimplicationsforrhythmmanagementandstrokeprevention: theAnTicoagulationandRiskFactorsinAtrialFibrillation(ATRIA)Study.JAMA2001,285, 2370-2375.(Pubitemid32424106)
5. FURBERG C.D., PSATY B.M., MANOLIO T.A., GARDIN J.M., SMITH V.E., RAUTAHARJU P.M., for the CHS Collaborative Research Group. - Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am. J. Cardiol., 1994, 74, 236-241.
6. PSATYB.M.,MANOLIOT.A.,KULLERL.H.etal.- Incidenceofandriskfactorsforatrialfibrillationinolderadults.Circulation,1997,96, 2455-2461.(Pubitemid27425856)
7. GUIZEL.,PIOTO.,LAVERGNET.LEHEUZEYJ-Y.- Lestroublesdurythmecardiaquedusujetâgé.Bull.Acad.NatleMéd, 2006,190,827-841.(Pubitemid44767444)
8. WOLF P.A., BENJAMIN E.J., BELANGER A.J., KANNEL W.B., LEVY D., D'AGOSTINO R.B. -Secular trends in the prevalence of atrial fibrillation. The Framingham Study. Am. Heart J., 1996, 131, 790-795. (Pubitemid 26116354)
9. FRIBERG J., BUCH P., SCHARLING H. et al. - Rising rates of hospital admissions for atrial fibrillation. Epidemiology, 2003, 14, 666-672. (Pubitemid 40417013)
10. WANG T.J., LARSON M.G., LEVY D. et al. - Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality : the Framingham Heart Study. Circulation, 2003, 107, 2920-12905 (Pubitemid 36736633)
11. Atrial Fibrillation Investigators. -Risk factors for stoke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch. Intern. Med, 1994, 154, 1449-1457. [erratum p. 2254].
12. LINH.J.,WOLFP.A.,KELLY-HAYESM.etal.-Strokeseverityinatrialfibrillation. TheFraminghamStudy.Stroke,1996,27,1760-1764.(Pubitemid26332500)
13. BENJAMINE.,WOLFP.A.,D'AGOSTINOR.B.,SILBERSHATZH.,KANNELW.B.,LEVYD. -ImpactofAtrialFibrillationontheRiskofDeath.TheFraminghamHeartStudy.Circulation, 1998,98,946-952.(Pubitemid28446646)
14. JOUVEN X., DESNOS M., GUÉROT C, DUCIMETIÈRE P. - Idiopathic atrial fibrillation as a risk factor for mortality. The Paris Prospective Study I. Eur. Heart J., 1999, 20, 896-899.
15. LEVY S., MAAREK M., COUMEL P., GUIZE L., LEKIEFFRE J., MEDVEDOWSKY J.L., on behalf of the College of French Cardiologists. - Characterization of different subsets of atrial fibrillation in general practice in France : the ALFA Study. Circulation, 1999, 99, 3028-3035.
16. BECK A.T., RIAL W.Y., RICKELS K. - Short form of depression inventory : cross-validation. Psychol Rep., 1914, 34, 1184-1186.
17. PICHOT P., BOYER P., PULL C.B., REIN W., SIMON M., THIBAULT A. - Un questionnaire d'autoévaluation de la Symptomatologie dépressive. Le questionnaire QD2, forme abrégée QD2A. Revue de psychologie appliquée, 1984, 34, 323-340.
18. BENJAMIN EJ., LEVY D., VAZARI S.M., D'AGOSTINO R.B., BELANGER A.J., WOLF P.A. -Independent Risk Factors for Atrial Fibrillation in a Population-Based Cohort. The Framingham Heart Study. JAMA, 1994, 271, 840-844. (Pubitemid 24076851)
19. MITCHELL G.F., VASAN R.S., KEYES M.J. et al. - Pulse pressure and risk of new-onset atrial fibrillation. JAMA, 2007, 297, 709-715. (Pubitemid 46294560)
20. WANG T.J., PARISE H., LEVY D. et al. - Obesity and the risk of new-onset atrial fibrillation. JAMA, 2004, 292, 2471-2477. (Pubitemid 39552671)
21. DUBLIN S., FRENCH B., GLAZER N.L. et al. - Risk of new-onset atrial fibrillation in relation to body mass index. Arch. Intern. Med., 2006, 166, 2322-2328. (Pubitemid 44833356)
22. UMETANI K., KODAMA Y., NAKAMURA T. et al. - High prevalence of paroxysmal atrial fibrillation and/or atrial flutter in metabolic syndrome. Circ. J., 2007, 71, 252-255. (Pubitemid 46182700)
23. ANNIER B., THOMAS F., ESCHWEGE E. et al.- Cardiovascular risk markers associated with the metabolic syndrome in a large French population : the "SYMFONIE" study. Diabetes Metab., 2006, 32, 467-474.
24. GUIZEL,THOMASF,PANNIERB,BEANK,DANCHINN,BENETOSA.- Syndromemétabolique:prévalence,marqueursderisqueassocié setmortalitédansunepopulationfrançaisede62000sujets.Bull.Acad. NatleMed.2006,190,685-700.(Pubitemid44578076)
25. GAMI A.S., HODGE D.E., HERGES R.M. et al. - Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J. Am. Coll. Cardiol, 2007, 49, 565-571. (Pubitemid 46177437)
26. PEDERSEN O.D., SONDERGAARD P., NIELSEN T. et al. on behalf of the DIAMOND study group investigators. - Atrial fibrillation, ischaemic heart disease, and the risk of death in patients with heart failure. Eur. Heart J., 2006, 27, 2866-2870.
27. STEWART S., HART C.L., HOLE D.J., et al. - A population-based study of the long-term risks associated with atrial fibrillation : 20-year follow-up of the Renfrew/Paised study. Am. J. Med., 2002, 113, 359-364. (Pubitemid 35223606)
28. FANG M.C., SINGER D.E., CHANG Y. et al. - Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation. The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. Circulation, 2005, 112, 1687-1691. (Pubitemid 41368143)
29. LIP G. Y., FRISON L., GRIND M. - Effect of hypertension on anticoagulated patients with atrial fibrillation. Eur. Heart J., 2007, 28, 752-759. (Pubitemid 46439230)
30. HEALEY J.S., BARANCHUK A., CRYSTAL E., et al. - Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers : a meta-analysis. J. Am. Coll. Cardiol., 2005, 45, 1832-1839. (Pubitemid 40789940)
31. PITT B., ZANNAD F., REMME W. et al. - The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med., 1999, 341, 709-717.
32. PITT B., REMME W., ZANNAD F. el al. - Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N. Engl. J. Med., 2003, 348, 1309-1321. (Pubitemid 36384098)
33. PAZIAUDO.,PIOTO.,ROUSSEAUJ.etal.- Critèresprédictifsderécidivepré coced'untroubledurythmeatrialaprèsréductionparchocé lectriqueexterne.Arch.Mal.Cœur,2003,96,1169-1174.(Pubitemid38313399)
34. NATTEL S. - Aldosterone antagonism and atrial fibrillation : time for clinical assessment. Eur. Heart J., 2005, 26, 2079-2080. (Pubitemid 41407987)
35. NASR I.A., BOUZAMONDO A., HULOT J.S., DUBOURG O., LE HEUZEY J.Y., LECHAT P. - Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure : a meta-analysis. Eur. Heart J., 2007, 28, 457-462. (Pubitemid 47343566)